MIN KYEONG LEE, DMD
Dentist at Longwood Ave, Boston, MA
License number
Massachusetts DN1855515
Category
Dentist
Type
Dentist
Address
Address
188 Longwood Ave, Boston, MA 02115
Phone
(617) 432-4281
Organization information
See more information about MIN KYEONG LEE at bizstanding.comMin Kyeong Lee DMD
188 Longwood Ave, Boston, MA 02115
Industry:
Dentists
Phone:
(617) 432-4281 (Phone)
Min Kyeong Kyeong Lee
Professional information
Min Kyeong Lee, Boston MA
Specialties:
Dentist
Address:
188 Longwood Ave, Boston, MA 02115
Dr. Min Kyeong Lee, Boston MA - DMD (Doctor of Dental Medicine)
Specialties:
Dentistry
Address:
188 Longwood Ave, Boston 02115
(617) 432-4281 (Phone)
(617) 432-4281 (Phone)
Languages:
English
Dr. Min J Lee, Boston MA - MD (Doctor of Medicine)
Specialties:
Pediatrics
Age:
43
Address:
45 Francis St, Boston 02115
(617) 732-8155 (Phone), (617) 732-5766 (Fax)
26901 76Th Ave, New Hyde Park 11040
(718) 470-3204 (Phone), (718) 470-3204 (Fax)
850 Boylston St STE 5TH, Chestnut Hill 02467
(517) 732-9850 (Phone)
(617) 732-8155 (Phone), (617) 732-5766 (Fax)
26901 76Th Ave, New Hyde Park 11040
(718) 470-3204 (Phone), (718) 470-3204 (Fax)
850 Boylston St STE 5TH, Chestnut Hill 02467
(517) 732-9850 (Phone)
Languages:
English
Compositions And Methods For Enhancing Proteasome Activity
US Patent:
2013004, Feb 21, 2013
Filed:
Jan 28, 2011
Appl. No.:
13/575812
Inventors:
Daniel J. Finley - Jamaica Plain MA, US
Randall W. King - Brookline MA, US
Byung-Hoon Lee - Cambridge MA, US
Min J. Lee - Jamaica Plain MA, US
Timothy C. Gahman - Encinitas CA, US
Randall W. King - Brookline MA, US
Byung-Hoon Lee - Cambridge MA, US
Min J. Lee - Jamaica Plain MA, US
Timothy C. Gahman - Encinitas CA, US
Assignee:
President and Fellows of Harvard College - Cambridge MA
International Classification:
A61K 31/454, C12N 5/071, A61P 43/00, C40B 30/08, C12N 9/50, C07D 401/06, C12N 9/99, C12N 9/96
US Classification:
514326, 435184, 435375, 435188, 506 11, 435219, 546208
Abstract:
Proteinopathies result from the proteasome not acting efficiently enough to eliminate harmful proteins and prevent the formation of the pathogenic aggregates. As described herein, inhibition of proteasome-associated deubiquitinase Usp 14 results in increased proteasome efficiency. The present invention therefore provides novel compositions and methods for inhibition of Usp14, enhancement of proteasome activity and treatment of proteinopathies.